BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC.
The net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Proposed Public Offering
BioSig Technologies, Inc. to offer shares of common stock through underwritten public offering.
Offering Details
Offering made pursuant to effective shelf registration statement on Form S-3 declared by the SEC.
Use of Proceeds
Intending to use net proceeds for gold bullion purchase, working capital, and general corporate purposes.
- The completion of the offering is subject to market conditions with uncertainty about timing, size, and terms.
- Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Investors should carefully review all related documents before considering investing in this offering to have a comprehensive understanding of the opportunity and risks involved.